No differences within coalition govt in Maharashtra: Sharad Pawar

After taking over as CM, Thackeray had plans to work on several issues, but priorities changed with the outbreak of coronavirus, Pawar said.

PTI

July 07, 2020 / 22:58 IST

File image

NCP chief Sharad Pawar said on July 7 that he met Maharashtra Chief Minister Uddhav Thackeray to discuss issues of the state, and there was no bickering within the ruling Maha Vikas Aghadi (MVA).

Pawar was speaking to reporters after a meeting with a traders' association here.

Asked about his meeting with the chief minister at 'Matoshree', Thackeray's residence in Mumbai, on Monday, Pawar quipped that newspaper reports about differences within the Shiv Sena-NCP-Congress alliance was news to him. "There are no differences. The discussions with the CM were related to the issues that are before the state and there were no other issues," he said.

Reports about tensions in the ruling coalition emerged after the home department's order of transfer of 10 deputy commissioners of police in Mumbai was rescinded. The Home portfolio is held by the NCP.

Talking about the issue, Pawar said transfers of IPS or IAS officers are being done with the chief minister's approval.

COVID-19 Vaccine

Frequently Asked Questions

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

Show